找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biopharmaceuticals, an Industrial Perspective; Gary Walsh,Brendan Murphy Book 1999 Springer Science+Business Media B.V. 1999 biochemistry.

[復(fù)制鏈接]
查看: 31395|回復(fù): 64
樓主
發(fā)表于 2025-3-21 19:49:53 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱Biopharmaceuticals, an Industrial Perspective
影響因子2023Gary Walsh,Brendan Murphy
視頻videohttp://file.papertrans.cn/189/188318/188318.mp4
圖書封面Titlebook: Biopharmaceuticals, an Industrial Perspective;  Gary Walsh,Brendan Murphy Book 1999 Springer Science+Business Media B.V. 1999 biochemistry.
影響因子.Biopharmaceuticals, an Industrial Perspective. provides aunique and up-to-date insight into the biopharmaceutical industry.Largely written by industrial authors, its scope is multidisciplinary.Several chapters overview the production and medical applications ofspecific biopharmaceuticals. Other chapters detail additional relevantissues, including the stabilisation of biopharmaceutical products, EUbiopharmaceutical regulatory affairs and biopharmaceutical patent law.A series of four chapters reviews important validation issues asapplied to biopharmaceutical manufacturing. Additional issuesconsidered include biopharmaceutical information technology as well asviral and non-viral gene therapy. .The book is of particular relevance to scientists and alliedprofessionals already employed in the biopharmaceutical industry, orto those seeking employment within this industry. Its scope alsorenders it an ideal reference source for students undertaking advancedundergraduate or postgraduate courses in biotechnology, pharmaceuticalscience, biochemistry or medicine.
Pindex Book 1999
The information of publication is updating

書目名稱Biopharmaceuticals, an Industrial Perspective影響因子(影響力)




書目名稱Biopharmaceuticals, an Industrial Perspective影響因子(影響力)學(xué)科排名




書目名稱Biopharmaceuticals, an Industrial Perspective網(wǎng)絡(luò)公開度




書目名稱Biopharmaceuticals, an Industrial Perspective網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Biopharmaceuticals, an Industrial Perspective被引頻次




書目名稱Biopharmaceuticals, an Industrial Perspective被引頻次學(xué)科排名




書目名稱Biopharmaceuticals, an Industrial Perspective年度引用




書目名稱Biopharmaceuticals, an Industrial Perspective年度引用學(xué)科排名




書目名稱Biopharmaceuticals, an Industrial Perspective讀者反饋




書目名稱Biopharmaceuticals, an Industrial Perspective讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:13:18 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:37:33 | 只看該作者
Laser in der Medizin / Laser in Medicine reported being mild to moderate bone pain. Current issues being investigated include evaluation of the cost benefit of Filgrastim in various clinical settings and impact on survival in dose-intensive chemotherapy with Filgrastim given as an adjunct treatment.
地板
發(fā)表于 2025-3-22 07:07:58 | 只看該作者
Laser in der Medizin / Laser in Medicineset of activity and a shorter duration of action when compared to regular human insulin while maintaining equal glucose lowering ability. Insulin lispro provides better postprandial glucose control at a more convenient time relative to consumption of a meal.
5#
發(fā)表于 2025-3-22 12:34:09 | 只看該作者
Arbeitsgruppe Neuhaus/Borkowski/Lietzg regimen. Clinical studies comparing reteplase with the current standard thrombolytic agents have demonstrated that reteplase has a highly favourable pharmacological profile with prolonged half-life, low bleeding risk and low potential for antigenicity.
6#
發(fā)表于 2025-3-22 16:24:03 | 只看該作者
Biopharmaceutical Drug Development: A Case History, reported being mild to moderate bone pain. Current issues being investigated include evaluation of the cost benefit of Filgrastim in various clinical settings and impact on survival in dose-intensive chemotherapy with Filgrastim given as an adjunct treatment.
7#
發(fā)表于 2025-3-22 17:04:25 | 只看該作者
Insulin Lispro (Humalog),set of activity and a shorter duration of action when compared to regular human insulin while maintaining equal glucose lowering ability. Insulin lispro provides better postprandial glucose control at a more convenient time relative to consumption of a meal.
8#
發(fā)表于 2025-3-22 23:26:18 | 只看該作者
Reteplase, a recombinant plasminogen activator,g regimen. Clinical studies comparing reteplase with the current standard thrombolytic agents have demonstrated that reteplase has a highly favourable pharmacological profile with prolonged half-life, low bleeding risk and low potential for antigenicity.
9#
發(fā)表于 2025-3-23 03:30:56 | 只看該作者
Book 1999 and alliedprofessionals already employed in the biopharmaceutical industry, orto those seeking employment within this industry. Its scope alsorenders it an ideal reference source for students undertaking advancedundergraduate or postgraduate courses in biotechnology, pharmaceuticalscience, biochemistry or medicine.
10#
發(fā)表于 2025-3-23 07:34:36 | 只看該作者
Laser in der Medizin / Laser in Medicineinant FSH is more effective and efficient in ovarian stimulation, eventually leading to a higher chance for a pregnancy, than the traditional FSH derived from postmenopausal urine. In this chapter, various aspects on the molecular biology, pharmacokinetics, preclinal tests, and clinical trials are addressed.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 12:18
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
保德县| 乐昌市| 舞阳县| 绥阳县| 如东县| 双柏县| 汤阴县| 石门县| 古田县| 汝南县| 塔河县| 明光市| 安陆市| 义乌市| 固安县| 贵州省| 开封市| 兴国县| 南投市| 富民县| 东明县| 安新县| 冷水江市| 郯城县| 拉孜县| 大余县| 堆龙德庆县| 迭部县| 丰城市| 荥经县| 玛多县| 德惠市| 兴城市| 文成县| 德安县| 孟村| 靖宇县| 通许县| 松阳县| 大田县| 竹溪县|